Eagle’s Eye View: What is the Safety and Tolerability of Inclisiran in Treating Hypercholesterolemia?

In this week’s View, Dr. Eagle explores longitudinal changes in pulmonary artery pressure late in life using data from the ARIC study. He then discusses the safety and tolerability of inclisiran for treatment of hypercholesterolemia. Finally, Dr. Eagle asses late gadolinium enhancement in hypertrophic cardiomyopathy and how it improves risk stratification based on current guidelines.

Twitter Links:

Clinical Topics: Dyslipidemia, Geriatric Cardiology, Heart Failure and Cardiomyopathies, Noninvasive Imaging, Homozygous Familial Hypercholesterolemia, Magnetic Resonance Imaging, Pulmonary Hypertension and Venous Thromboembolism

Keywords: EaglesEyeView, Dyspnea, Geriatrics, Pulmonary Artery, Hypercholesterolemia, PCSK9 Inhibitors, Cardiomyopathy, Hypertrophic, Magnetic Resonance Imaging

< Back to Listings